DNA-dependent protein kinase acts upstream of p53 in response to DNA damage

Nature

Volumn 394, Issue 6694, 1998, Pages 700-704

  Woo, Richard A ^a   McLure, Kevin G ^a   Lees Miller, Susan P ^a   Rancourt, Derrick E ^a   Lee, Patrick W K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DNA; HYDROGEN PEROXIDE; MITOMYCIN C; PROTEIN KINASE; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; GAMMA IRRADIATION; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR SUPPRESSOR GENE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; DNA DAMAGE; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, SCID; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MAMMALIA;

EID: 0032514485     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/29343     Document Type: Article

References (28)

1. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
2. Tishler, R. B., Calderwood, S. K., Coleman, C. N. & Price, B. D. Increases in sequence-specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53, 2212-2216 (1993).
3. Nelson, W. G. & Kastan, M. B. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14, 1815-1823 (1994).
4. Anderson, C. W. & Lees-Miller, S. P. The human DNA-activated protein kinase DNA-PK. Crit. Rev. Eukaryot. Gene Expr. 2, 283-314 (1992).
5. Gottlieb, T. M. & Jackson, S. P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72, 131-142 (1993).
6. Morozov, V. E., Falzon, M., Anderson, C. W. & Kuff, E. L. DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem. 269, 16684-16688 (1994).
7. Hendrickson, E. A. et al. A link between double-strand break-related repair and V(D)J recombination: The SCID mutation. Proc. Natl Acad. Sci. USA 88, 4061-4065 (1991).
8. Blunt, T. et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine SCID mutation. Cell 80, 813-823 (1995).
9. Lees-Miller, S. P. et al. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267, 1183-1185 (1995).
10. Kern, S. E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830 (1992).
11. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
12. El-Diery, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
13. Bogue, M. A., Zhu, C., Aguilar-Cordova, E., Donehower, L. A. & Both, D. B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in SCID mouse thymocytes. Genes Dev. 10, 553-565 (1996).
14. Guidos, C. J. et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in SCID lymphocyte precursors. Genes Dev. 10, 2038-2054 (1996).
15. Huang, L., Clarkin, K. C. & Wahl, G. M. p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. Cancer Res. 56, 2940-2944 (1996).
16. Nacht, M. et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10, 2055-2066 (1996).
17. Zhu, C., Bogue, M. A., Lim, D., Hasty, P. & Roth, D. B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389 (1996).
18. CS: a T-cell tumour supressor encoded at the mouse scid locus. Nature Genet. 17, 483-486 (1997).
19. Hollstein, M. et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994).
20. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S., Appella, E. & Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041-5049 (1992).
21. Shieh, S.-Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (1997)
22. Abbondanzo, S. J., Gadi, I. & Stewart, C. L. Derivation of embryonic stem cell lines. Methods Enzymol. 225, 803-823 (1993).
23. McLure, K. G. & Lee, P. W. K. How p53 binds DNA as a tetramer. EMBO J. 17, 3342-3350 (1998).
24. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).
25. Neumann, J. R., Morency, C. A. & Russian, K. O. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5, 444-448 (1987).
26. Wong, H., Anderson, W. D., Cheng, T. & Riabowol, K. T. Monitoring mRNA expression by polymerase chain reaction: The "primer-dropping" method. Anal. Biochem. 223, 251-258 (1994).
27. Skup, D. & Millward, S. Reovirus-induced modification of cap-dependent translation in infected L cells. Proc. Natl Acad. Sci. USA 77, 152-156 (1980).
28. Milner, J., Medcalf, E. A. & Cook, A. C. Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes. Mol. Cell. Biol. 11, 12-19 (1991).